SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
SANUWAVE Health, Inc.NASDAQ: SNWV
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization grows, but more slowly than its trailing trend
Q1 FY2026 depreciation & amortization of $312K rose 13.9% year over year, behind the +32.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 51.9% from the prior quarter. Over 3 fiscal years it compounded at +10.5% a year.
Context
- Depreciation & amortization amounted to 2.9% of revenue in FY2025, down 0.6 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +13.9% toward the trailing-twelve-month pace of +32.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2025
- 1.28M USD
- Year-over-year change
- +12.1%
- 4-year CAGR
- +0.9%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.28M | +12.1% |
| FY2024 | 2024-12-31 | 1.15M | +11.4% |
| FY2023 | 2023-12-31 | 1.03M | +8.0% |
| FY2022 | 2022-12-31 | 952K | -23.0% |
| FY2021 | 2021-12-31 | 1.24M | — |
Depreciation & Amortization vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 depreciation & amortization of $1.59M is the 8th highest of the 11 companies compared; the peer median is $2.77M.
- Its year-over-year change of +32.3% is the 4th highest of 11, against a peer median of -1.8%.
- Depreciation & amortization amounts to 3.6% of revenue for SNWV, versus a peer median of 7.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $21.08M | +133.7% | +51.8% | 14.5% | |
| LTM Mar 2026 | $20.37M | -2.6% | -4.2% | 5.8% | |
| LTM Dec 2025 | $11.7M | -0.3% | +0.5% | 89.8% | |
| LTM Mar 2026 | $4.32M | -7.0% | +40.4% | 7.5% | |
| LTM Mar 2026 | $2.79M | -10.3% | +0.1% | 9.9% | |
| LTM Mar 2026 | $2.74M | -56.6% | -11.6% | 2.3% | |
| LTM Mar 2026 | $1.67M | -1.0% | +15.4% | 4.1% | |
| LTM Mar 2026 | $1.59M | +32.3% | +10.5% | 3.6% | |
| LTM Mar 2026 | $786.79K | +70.5% | +36.1% | — | |
| LTM Mar 2026 | $672K | +1192.3% | +38.7% | 7.0% | |
| LTM Mar 2026 | $441K | -24.4% | -27.0% | 0.6% | |
| Peer median (excluding SNWV) | $2.77M | -1.8% | +7.9% | 7.0% | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 13.01M | 16.74M | 20.4M | 32.63M | 44.05M |
| Cost of Revenue | 4.99M | 4.33M | 6.04M | 8.08M | 10.08M |
| Gross Profit | 8.02M | 12.41M | 14.36M | 24.55M | 33.97M |
| Gross Margin | 61.7% | 74.1% | 70.4% | 75.2% | 77.1% |
| Research & Development | 1.1M | 567K | 579K | 673K | 1.35M |
| Selling, General & Admin | 20.28M | 20.03M | 13.57M | 17.67M | 26.79M |
| Operating Expenses | 22.17M | 21.36M | 14.9M | 19.13M | 29.02M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| EBITDA | (18.9M) | 4.79M | (9.15M) | (16.56M) | 19.43M |
| EBITDA Margin | -145.3% | 28.6% | -44.9% | -50.8% | 44.1% |
| Operating Income | (14.14M) | (8.95M) | (540K) | 5.42M | 4.95M |
| Operating Margin | -108.7% | -53.5% | -2.6% | 16.6% | 11.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 7.1M | 14.13M | 15.62M | 13.64M | 6.25M |
| Other Income / Expenses | (13.09M) | (1.34M) | (25.26M) | (36.76M) | 6.95M |
| Income Before Tax | (27.23M) | (10.29M) | (25.8M) | (31.35M) | 11.9M |
| Pre-Tax Margin | -209.3% | -61.5% | -126.5% | -96.1% | 27.0% |
| Income Tax Expense | 28K | 2K | 4K | 27K | 86K |
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Net Margin | -209.5% | -61.5% | -126.5% | -96.1% | 26.8% |
| EPS (Basic) | (19.72) | (7.02) | (12.19) | (7.03) | 1.38 |
| EPS (Diluted) | (19.72) | (7.02) | (12.19) | (7.03) | 0.41 |
| Weighted Avg Shares | 1.38M | 1.47M | 2.12M | 4.46M | 8.56M |
| Weighted Avg Shares (Diluted) | 1.38M | 1.47M | 2.12M | 4.46M | 9.08M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.